SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-303532
Filing Date
2011-11-09
Accepted
2011-11-09 09:54:40
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d230514d10q.htm 10-Q 442726
2 SECTION 302 CEO CERTIFICATION d230514dex311.htm EX-31.1 5972
3 SECTION 302 CFO CERTIFICATION d230514dex312.htm EX-31.2 5970
4 SECTION 906 CEO AND CFO CERTIFICATION d230514dex321.htm EX-32.1 5698
  Complete submission text file 0001193125-11-303532.txt   2142937

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgen-20110930.xml EX-101.INS 297245
6 XBRL TAXONOMY EXTENSION SCHEMA rgen-20110930.xsd EX-101.SCH 15434
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20110930_cal.xml EX-101.CAL 37002
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20110930_def.xml EX-101.DEF 97060
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20110930_lab.xml EX-101.LAB 91231
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20110930_pre.xml EX-101.PRE 106379
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 111189900
SIC: 2836 Biological Products, (No Diagnostic Substances)